KRYS
NASDAQ HealthcareKrystal Biotech, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $251.31 |
|---|---|
| Volume | 196,541 |
| Market Cap | 7.35B |
| Beta | 0.510 |
| RSI (14-Day) | 43.6 |
| 200-Day MA | $196.17 |
| 50-Day MA | $269.15 |
| 52-Week High | $298.30 |
| 52-Week Low | $122.80 |
| P/E Ratio | 36.80 |
| Forward P/E | 23.15 |
| Price / Book | 6.02 |
🎯 Investment Strategy Scores
How KRYS scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
44/100
High dividend yield + low volatility
🚀 Moon Shot
24/100
High growth potential (high beta + oversold)
🔪 Falling Knife
20/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
60/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
68/100
Large-cap, institutional-quality stocks
Find KRYS in your text
Paste any text on the homepage — the tool will extract KRYS and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.